Overview

Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients.

Status:
Unknown status

Trial end date:
2014-03-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether bevacizumab, capecitabine and oxaliplatin are an effective and safe first line of treatment for elderly patients with metastatic colorectal adenocarcinoma.

Phase:

Phase 2

Details

Lead Sponsor:

Grupo Espanol Multidisciplinario del Cancer Digestivo

Treatments:

Bevacizumab
Capecitabine
Oxaliplatin